Kang Cheng, Lu Dakai
Department of Otolaryngology-Head and Neck Surgery, HuaMei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Front Med (Lausanne). 2022 Feb 14;8:788754. doi: 10.3389/fmed.2021.788754. eCollection 2021.
Microneedling is a promising method for the treatment of acne scars, while the effect of microneedling combined with platelet-rich plasma (PRP) remains unknown. We performed a meta-analysis of controlled studies to compare the efficacy and safety of microneedling treatment with and without additional PRP in patients with acne scars.
Randomized and non-randomized controlled studies were identified by search of Medline, Embase, and Cochrane's Library databases. Results were pooled with a random-effects model, incorporating the possible heterogeneity.
Four randomized and 10 split-face non-randomized controlled studies with 472 patients were included. Compared to microneedling therapy without PRP, combined treatment with microneedling and PRP was associated with increased odds of clinical improvement of >50% in Goodman's qualitative scale [GQS: odds ratio (OR): 2.97, 95% confidence interval (CI): 1.96-4.51, < 0.001; = 0%], and a significantly improved mean GQS score (mean difference: -0.32, 95% CI: -0.44 to -0.20, < 0.001; = 0%). Combined treatment was associated with a higher patient satisfying rate (OR: 4.15, 95% CI: 2.13 to 8.09, < 0.001; = 53%), while the incidence of severe adverse events such as severe erythema (OR: 1.59, 95% CI:.73 to 3.46, = 0.24; = 0%) and severe edema (OR: 1.14, 95% CI: 0.47 to 2.76, = 0.77; = 0%) were not significantly different.
Combined treatment with microneedling with PRP is more effective than microneedling without PRP for patients with acne scars.
微针疗法是治疗痤疮瘢痕的一种有前景的方法,而微针联合富血小板血浆(PRP)的效果尚不清楚。我们进行了一项对照研究的荟萃分析,以比较微针治疗联合或不联合PRP对痤疮瘢痕患者的疗效和安全性。
通过检索Medline、Embase和Cochrane图书馆数据库确定随机和非随机对照研究。结果采用随机效应模型合并,纳入可能的异质性。
纳入了4项随机和10项半脸非随机对照研究,共472例患者。与不使用PRP的微针疗法相比,微针联合PRP治疗在古德曼定性量表(GQS)中临床改善>50%的几率增加[GQS:优势比(OR):2.97,95%置信区间(CI):1.96 - 4.51,P < 0.001;I² = 0%],且GQS平均评分显著改善(平均差:-0.32,95% CI:-0.44至-0.20,P < 0.001;I² = 0%)。联合治疗的患者满意率更高(OR:4.15,95% CI:2.13至8.09,P < 0.001;I² = 53%),而严重不良事件如严重红斑(OR:1.59,95% CI:0.73至3.46,P = 0.24;I² = 0%)和严重水肿(OR:1.14,95% CI:0.47至2.76,P = 0.77;I² = 0%)的发生率无显著差异。
对于痤疮瘢痕患者,微针联合PRP治疗比不联合PRP的微针治疗更有效。